West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:03:36 2026-09-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 362.31 USD | -1.17% |
|
+4.64% | +31.68% |
| Market Cap | 25.5B 22.23B 20.99B 19.06B 35.72B 2,447B 35.87B 251B 97.04B 1,244B 95.78B 93.66B 4,002B | P/E 2026 * |
42.3x | P/E 2027 * | 36.7x |
|---|---|---|---|---|---|
| Enterprise Value | 24.99B 21.8B 20.58B 18.69B 35.01B 2,398B 35.16B 247B 95.13B 1,219B 93.89B 91.81B 3,923B | EV / Sales 2026 * |
7.41x | EV / Sales 2027 * | 6.84x |
| Free-Float |
92.88% | Yield 2026 * |
0.25% | Yield 2027 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | -1.17% | ||
| 1 week | +4.64% | ||
| Current month | +6.22% | ||
| 1 month | +2.70% | ||
| 3 months | +10.48% | ||
| 6 months | +50.76% | ||
| Current year | +31.68% |
| 1 week | 345.15 |  | 370.67 |
| 1 month | 331.99 | | 370.67 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% | ||
| 9/8/26 | Exercice | Head of Human Resources | 24,405 | 0.0347% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.17% | +4.64% | +42.17% | -7.72% | 25.5B | |
| +0.37% | +0.65% | -24.57% | +1.93% | 178B | |
| -0.69% | +1.29% | -3.10% | +11.50% | 118B | |
| -0.20% | -3.98% | +6.47% | +71.79% | 58.92B | |
| -0.24% | +1.74% | -3.26% | -31.97% | 49.29B | |
| -0.22% | -0.37% | +10.27% | +40.45% | 48.17B | |
| +1.61% | +7.61% | +32.47% | -5.11% | 33.72B | |
| -1.49% | -2.74% | - | - | 27.76B | |
| +1.02% | +5.99% | +6.51% | -15.81% | 22.1B | |
| -2.33% | -0.36% | -8.97% | +3.49% | 21.03B | |
| Average | -0.33% | +1.63% | +6.44% | +7.62% | 58.19B | |
| Weighted average by Cap. | -0.16% | +0.98% | -3.41% | +10.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.94B 2.78B 2.52B 4.73B 324B 4.75B 33.28B 12.84B 165B 12.67B 12.39B 530B | 3.59B 3.13B 2.95B 2.68B 5.02B 344B 5.04B 35.36B 13.65B 175B 13.47B 13.17B 563B |
| Net income | 617M 538M 508M 462M 865M 59.25B 869M 6.09B 2.35B 30.12B 2.32B 2.27B 96.92B | 703M 613M 578M 525M 984M 67.42B 988M 6.93B 2.67B 34.27B 2.64B 2.58B 110B |
| Net Debt | -503M -439M -414M -376M -705M -48.29B -708M -4.96B -1.92B -24.55B -1.89B -1.85B -79B | -974M -849M -802M -728M -1.36B -93.42B -1.37B -9.6B -3.71B -47.49B -3.66B -3.58B -153B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | $362.31 | -1.17% | 1,457,546 |
| 26-09-17 | $366.60 | +1.27% | 474,057 |
| 26-09-16 | $362.01 | -0.82% | 621,048 |
| 26-09-15 | $365.00 | +2.76% | 981,894 |
| 26-09-14 | $355.20 | +2.59% | 625,555 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
